CIDARA THERAPEUTICS INC (CDTX) Stock Income Statement
USA - NASDAQ:CDTX - US1717572069 - Common Stock
93.12 USD
-3.04 (-3.16%)
92.0229 USD
-1.1 (-1.18%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 1.27M | 63.91M | 64.45M | 49.57M | |||
| Cost Of Goods | N/A | N/A | 1.52M | 0.00 | N/A | |||
| Gross Profit | N/A | N/A | 62.38M | 64.45M | N/A | |||
| Operating Expenses | 124.23M | 92.49M | 86.86M | 97.95M | 91.83M | |||
| Research and Development | 108.72M | 71.88M | 68.53M | 77.41M | 73.09M | |||
| Selling, General, and Administrative Expenses | 24.95M | 20.61M | 18.33M | 20.55M | 18.74M | |||
| Operating Income | -124.23M | -91.22M | -24.48M | -33.50M | -42.26M | |||
| Interest Income/Expense | 7.24M | 5.81M | 2.00M | 191.00K | -212.00K | |||
| Other Income/Expense | N/A | N/A | N/A | N/A | N/A | |||
| Non Recurring Items | N/A | -84.88M | N/A | N/A | N/A | |||
| Income Before Taxes | -117.10M | -170.29M | -22.49M | -33.31M | -42.47M | |||
| Income Tax | N/A | 0.00 | 443.00K | 272.00K | N/A | |||
| Net Income | -117.49M | -169.83M | -22.93M | -33.58M | -42.47M | |||
| EBITDA | -124.03M | -90.99M | -24.36M | -33.36M | -42.07M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -11.12 | -26.74 | -5.25 | -9.61 | -16.19 | |||
| Non GAAP EPS | -11.13 | -11.49 | -4.80 | -9.60 | -16.80 | |||
| Statistics | ||||||||
| Gross Profit Margin | N/A | N/A | 97.62% | 100.00% | N/A | |||
| Profit Margin | N/A | -13319.76% | -35.88% | -52.11% | -85.67% | |||
| Operating Profit Margin | N/A | -7154.43% | -38.31% | -51.98% | -85.24% | |||
All data in USD